These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28787718)

  • 1. Antenatal Treatment with Intravenous Immunoglobulin to Prevent Gestational Alloimmune Liver Disease: Comparative Effectiveness of 14-Week versus 18-Week Initiation.
    Whitington PF; Kelly S; Taylor SA; Nóbrega S; Schreiber RA; Sokal EM; Hibbard JU
    Fetal Diagn Ther; 2018; 43(3):218-225. PubMed ID: 28787718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient neonatal liver disease after maternal antenatal intravenous Ig infusions in gestational alloimmune liver disease associated with neonatal haemochromatosis.
    Baruteau J; Heissat S; Broué P; Collardeau-Frachon S; Bouvier R; Fabre M; Debiec H; Ronco P; Uzan M; Narcy P; Cordier MP; Lachaux A; Lamireau T; Elleau C; Filet JP; Mitanchez D; Dupuy MP; Salaün JF; Odent S; Davison J; Debray D; Guigonis V
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):629-35. PubMed ID: 25079484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin.
    Whitington PF; Kelly S
    Pediatrics; 2008 Jun; 121(6):e1615-21. PubMed ID: 18474533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Gestational Alloimmune Liver Disease on Fetal and Infant Morbidity and Mortality.
    Taylor SA; Kelly S; Alonso EM; Whitington PF
    J Pediatr; 2018 May; 196():123-128.e1. PubMed ID: 29499991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of neonatal hemochromatosis as gestational alloimmune liver disease with intravenous immunoglobulin.
    Jimenez-Rivera C; Gupta A; Feberova J; de Nanassy JA; Boland MP
    J Neonatal Perinatal Med; 2014; 7(4):301-4. PubMed ID: 25468619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis.
    Whitington PF; Hibbard JU
    Lancet; 2004 Nov 6-12; 364(9446):1690-8. PubMed ID: 15530630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.
    Lakkaraja M; Berkowitz RL; Vinograd CA; Manotas KC; Jin JC; Ferd P; Gabor J; Wissert M; McFarland JG; Bussel JB
    Am J Obstet Gynecol; 2016 Oct; 215(4):471.e1-9. PubMed ID: 27131591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Japanese experience and pharmacokinetics of antenatal maternal high-dose immunoglobulin treatment as a prophylaxis for neonatal hemochromatosis in siblings.
    Okada N; Sasaki A; Saito J; Mitani Y; Yachie A; Takahashi H; Matsubara S; Tenkumo C; Tanaka H; Hata T; Motomura K; Nagasawa J; Wada Y; Sako M; Yamaguchi K; Matsumoto K; Nakamura H; Sago H; Mizuta K
    J Matern Fetal Neonatal Med; 2020 Jan; 33(1):142-148. PubMed ID: 29890876
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia.
    Lakkaraja M; Jin JC; Manotas KC; Vinograd CA; Ferd P; Gabor J; Wissert M; Berkowitz RL; McFarland JG; Bussel JB
    Transfusion; 2016 Oct; 56(10):2449-2454. PubMed ID: 27611703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational Alloimmune Liver Disease: A Devastating Condition Preventable With Maternal Intravenous Immunoglobulin.
    Anastasio HB; Grundy M; Birsner ML; Blakemore KJ
    Obstet Gynecol; 2016 Nov; 128(5):1092-1094. PubMed ID: 27741190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized Trial.
    Paridaans NP; Kamphuis MM; Taune Wikman A; Tiblad E; Van den Akker ES; Lopriore E; Challis D; Westgren M; Oepkes D
    Fetal Diagn Ther; 2015; 38(2):147-53. PubMed ID: 25896635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylactic prenatal therapy with intravenous immunoglobulins for patients at risk for neonatal haemochromatosis].
    Faas D; Axt-Fliedner R; Zimmer KP; Heckmann M
    Z Geburtshilfe Neonatol; 2011 Dec; 215(6):246-9. PubMed ID: 22274935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational alloimmune liver disease with alpha thalassaemia in a neonate.
    Banait N; Varanasi SV; Nayak A; Talukder K
    BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38514166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal hemochromatosis.
    Feldman AG; Whitington PF
    J Clin Exp Hepatol; 2013 Dec; 3(4):313-20. PubMed ID: 25755519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia.
    Berkowitz RL; Kolb EA; McFarland JG; Wissert M; Primani A; Lesser M; Bussel JB
    Obstet Gynecol; 2006 Jan; 107(1):91-6. PubMed ID: 16394045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmapheresis as an alternative to high-dose intravenous immunoglobulin in the prevention of gestational alloimmune liver disease.
    Hutchings G; Williams O; Sokal E; Wittington PF
    Fetal Diagn Ther; 2013; 34(3):180-3. PubMed ID: 23860191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis.
    Nguyen T; Alraqum E; Razzaque Ahmed A
    Int Immunopharmacol; 2015 May; 26(1):1-3. PubMed ID: 25765353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal hemolysis after intravenous immunoglobulin treatment in fetal and neonatal alloimmune thrombocytopenia.
    Rink BD; Gonik B; Chmait RH; O'Shaughnessy R
    Obstet Gynecol; 2013 Feb; 121(2 Pt 2 Suppl 1):471-3. PubMed ID: 23344412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial.
    Berkowitz RL; Lesser ML; McFarland JG; Wissert M; Primiani A; Hung C; Bussel JB
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):249-55. PubMed ID: 17666597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin.
    Rand EB; Karpen SJ; Kelly S; Mack CL; Malatack JJ; Sokol RJ; Whitington PF
    J Pediatr; 2009 Oct; 155(4):566-71. PubMed ID: 19560784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.